Status:
UNKNOWN
Echocardiographic Manifestation in Patients With Omicron Variant of COVID-19
Lead Sponsor:
RenJi Hospital
Conditions:
COVID-19
Eligibility:
All Genders
18-75 years
Brief Summary
The cardiovascular scenario associated with omicron, the new variant of severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) that causes coronavirus disease 2019 (COVID-19), remains unclear. W...
Detailed Description
COVID-19 affects the cardiovascular system, and the presence of cardiovascular disease (CAD) and risk factors is associated with worse clinical outcomes in infected patients. However, there is a pauci...
Eligibility Criteria
Inclusion
- Aged 18-75 years old
- Half male and half female
- Admitted to hospital with confirmed omicron infection
- Able to receive an echocardiographic examination
- Written informed consents
- Healthy volunteers, matched for age and gender, are enrolled as the control group
Exclusion
- People under the age of 18 years old
- Inability to lie or maintain posture during the echocardiographic examination
Key Trial Info
Start Date :
May 30 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 30 2022
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT05379543
Start Date
May 30 2022
End Date
December 30 2022
Last Update
May 18 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Renji Hospital
Shanghai, China, 200127